Avita Medical
AVITA Medical is a leading therapeutic acute wound care company dedicated to transforming lives through innovative skin healing technologies. Their platform includes the FDA-approved RECELL System, which harnesses the healing properties of a patient’s own skin to create Spray-On Skin cells, providing an innovative solution for burn, trauma, or surgical wounds. The company also holds exclusive rights to market, sell, and distribute biosynthetic wound matrices like PermeaDerm and Cohealyx, and is exploring the potential of their technology platform across various skin-related indications. AVITA Medical emphasizes patient-centered care, innovation, quality, and integrity in their mission to improve clinical outcomes and accelerate patient recovery.
Industries
Nr. of Employees
medium (51-250)
Avita Medical
Products
Autologous spray-on skin cell system (point-of-care)
A clinical system that prepares an autologous cell suspension from a small skin sample for immediate application to wounds at the point-of-care to promote skin healing.
Biosynthetic primary wound dressing
A biosynthetic wound matrix designed to function as a primary dressing that adheres in a single application for wound management.
Collagen-based dermal matrix for full-thickness wounds
A collagen dermal matrix intended for management of full-thickness wounds.
Autologous spray-on skin cell system (point-of-care)
A clinical system that prepares an autologous cell suspension from a small skin sample for immediate application to wounds at the point-of-care to promote skin healing.
Biosynthetic primary wound dressing
A biosynthetic wound matrix designed to function as a primary dressing that adheres in a single application for wound management.
Collagen-based dermal matrix for full-thickness wounds
A collagen dermal matrix intended for management of full-thickness wounds.
Services
Education and training for healthcare professionals on the preparation and application of autologous cell suspensions and use of wound matrices.
Design and conduct of clinical studies and collection of patient outcomes and real-world evidence to support regulatory submissions and publications.
Education and training for healthcare professionals on the preparation and application of autologous cell suspensions and use of wound matrices.
Design and conduct of clinical studies and collection of patient outcomes and real-world evidence to support regulatory submissions and publications.
Expertise Areas
- Autologous cellular therapy development
- Acute wound care and burn treatment
- Clinical trial management and real-world evidence generation
- Regulatory compliance and market authorization
Key Technologies
- Autologous cell suspension (spray-on) therapy
- Point-of-care cell processing
- Biosynthetic wound matrix materials
- Collagen-based dermal matrices
News & Updates
Announcement of submission of FDA PMA supplement for RECELL GO system.
The company rejoined the Russell 3000 Index, highlighting its growth and market recognition.
A report on the largest real-world analysis of AVITA Medical's platform.
Announcement of the company's first clinical publication demonstrating the efficacy of their platform.
RECELL GO System FDA Approval
The RECELL GO System received FDA approval, marking a significant milestone in product development.
The RECELL platform was recognized for surgical innovation.
Announcement of submission of FDA PMA supplement for RECELL GO system.
The company rejoined the Russell 3000 Index, highlighting its growth and market recognition.
A report on the largest real-world analysis of AVITA Medical's platform.
Announcement of the company's first clinical publication demonstrating the efficacy of their platform.
RECELL GO System FDA Approval
The RECELL GO System received FDA approval, marking a significant milestone in product development.
The RECELL platform was recognized for surgical innovation.